| BIOAGE LABS INC. O.N. |
| USA |
| Gesundheit |
| US09077V1008 / A40D7P |
| Y7G (Frankfurt) / BIOA (NASDAQ) |
| FRA:Y7G, ETR:Y7G, Y7G:GR, NASDAQ:BIOA |
| - |
| https://bioagelabs.com/ |
|
BioAge Labs Inc. is a biotechnology company focused on discovering and developing therapies that can enhance the human lifespan and address age-related diseases. By leveraging advanced technologies like artificial intelligence and genomics, BioAge La..
>Volltext.. |
| 958.53 Mio. EUR |
| 630.35 Mio. EUR |
| 8.95 Mio. EUR |
| -88.05 Mio. EUR |
| -78.03 Mio. EUR |
| -2.09 EUR |
| 3.5 Mio. EUR |
| 209.79 Mio. EUR |
| -76.63 Mio. EUR |
| 24.21 |
| 565.72% |
| -18.53% |
| - |
| - |
| - |
| - |
| BIOAGE LABS |
| 01.08.26 |
|